This HTML5 document contains 130 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n11http://dx.doi.org/10.1016/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q38508715
rdf:type
wikibase:Item
schema:description
1995年論文 article scientifique artigo científico bilimsel makale мақолаи илмӣ vědecký článek 1995年论文 articolo scientifico bài báo khoa học научни чланак vetenskaplig artikel სამეცნიერო სტატია vitenskapelig artikkel 1995 nî lūn-bûn artikulong pang-agham artículu científicu espublizáu en 1995 tieteellinen artikkeli teaduslik artikkel tudományos cikk artículo científico scientific article published on August 1995 1995年论文 naučni članak 1995年論文 научная статья 1995년 논문 บทความทางวิทยาศาสตร์ artigo científico vitskapeleg artikkel 1995年論文 vedecký článok wetenschappelijk artikel 1995年论文 articol științific artikel ilmiah научни чланак wissenschaftlicher Artikel artikull shkencor artykuł naukowy 1995年论文 videnskabelig artikel 1995年論文 scientific article published on August 1995 scientific article published on August 1995 1995年论文 научна статия наукова стаття, опублікована в серпні 1995 مقالة علمية نشرت في أغسطس 1995 scienca artikolo artigo científico מאמר מדעי επιστημονικό άρθρο 1995年の論文 article scientific 1995年論文 বৈজ্ঞানিক নিবন্ধ article científic 1995年论文
p:P577
wds:Q38508715-0FCC7C6C-0D57-4525-9AEE-79620B06BA5E
wdt:P577
1995-08-01T00:00:00Z
p:P407
wds:Q38508715-BDF9F40F-162B-401D-89A4-95EE6A553058
wdt:P407
wd:Q1860
p:P2860
wds:Q38508715-AF9E2FBB-FB37-4D8B-BCEE-ABD9DDF4592F wds:Q38508715-C5FABF10-A396-443D-B58C-EE877DF8843A wds:Q38508715-C794BF39-980B-408E-B1FF-52761375184A wds:Q38508715-D493E894-3B6F-4B1E-907B-2EBDED2C655E wds:Q38508715-EC7D64A8-26CD-48CF-9C15-4FD60C24DC25 wds:Q38508715-F541FE3C-40E3-4D91-902A-BF03363D3C20 wds:Q38508715-F6FCFA92-885A-4982-B4FE-F238EC526638 wds:Q38508715-FAEEBBF1-C6F1-44AA-A65E-1AA65649908A wds:Q38508715-029FFEA8-F6F5-4EA6-BD77-288355E0F15E wds:Q38508715-218FEB0F-7893-4D9F-B3E3-7757C7CA0823 wds:Q38508715-5E3F3D14-BC3B-4752-83D0-F97407B2CBC8 wds:Q38508715-5E5AE9E2-7343-4CDC-9E64-F71DF1B541BD wds:Q38508715-675CB9CB-9728-43D8-B245-B8575351635E wds:Q38508715-89BB0BCB-654C-469F-B00B-99912352A705 wds:Q38508715-A9166C65-5CCD-4007-AE7D-31225D0C405B wds:Q38508715-A9A98BE5-AB8C-4033-BAD3-9BC450E00301
wdt:P2860
wd:Q69186416 wd:Q70046784 wd:Q40316334 wd:Q72836831 wd:Q69174434 wd:Q48572611 wd:Q70359468 wd:Q67903635 wd:Q38565755 wd:Q41037526 wd:Q67982698 wd:Q37923486 wd:Q68257351 wd:Q44678153 wd:Q72306178 wd:Q41194137
p:P2093
wds:Q38508715-68E9B701-1530-474A-A27C-3A0A252EA60D wds:Q38508715-03985A1E-42AA-4953-954F-9F041C267F1B
wdt:P2093
A R Scialli K J Jestila
rdfs:label
Sustained benefits of leuprolide acetate with or without subsequent medroxyprogesterone acetate in the nonsurgical management of leiomyomata uteri. Sustained benefits of leuprolide acetate with or without subsequent medroxyprogesterone acetate in the nonsurgical management of leiomyomata uteri. Sustained benefits of leuprolide acetate with or without subsequent medroxyprogesterone acetate in the nonsurgical management of leiomyomata uteri.
skos:prefLabel
Sustained benefits of leuprolide acetate with or without subsequent medroxyprogesterone acetate in the nonsurgical management of leiomyomata uteri. Sustained benefits of leuprolide acetate with or without subsequent medroxyprogesterone acetate in the nonsurgical management of leiomyomata uteri. Sustained benefits of leuprolide acetate with or without subsequent medroxyprogesterone acetate in the nonsurgical management of leiomyomata uteri.
schema:name
Sustained benefits of leuprolide acetate with or without subsequent medroxyprogesterone acetate in the nonsurgical management of leiomyomata uteri. Sustained benefits of leuprolide acetate with or without subsequent medroxyprogesterone acetate in the nonsurgical management of leiomyomata uteri. Sustained benefits of leuprolide acetate with or without subsequent medroxyprogesterone acetate in the nonsurgical management of leiomyomata uteri.
p:P1476
wds:Q38508715-4A7FA430-D0F6-4C8E-A2BB-6FB369881E42
wdt:P1476
Sustained benefits of leuprolide acetate with or without subsequent medroxyprogesterone acetate in the nonsurgical management of leiomyomata uteri
p:P304
wds:Q38508715-4DD93B08-FA5E-4E9C-9B68-3CA9AB6A586D
wdt:P304
313-320
p:P31
wds:Q38508715-872AD81B-F02F-446F-9F1C-8624FD51335E
wdt:P31
wd:Q13442814
p:P921
wds:Q38508715-A78C1054-BB69-45BC-924F-F14C3F6177CB wds:Q38508715-8570DC6B-BEAC-4F9E-8ECE-28F727B19532
wdt:P921
wd:Q2823834 wd:Q907160
p:P698
wds:Q38508715-501504CA-4F45-4E45-AA1F-3EEDD40A7E96
wdtn:P698
n12:7615109
wdt:P698
7615109
p:P1433
wds:Q38508715-F4D1489D-1941-4735-BF82-0EF5037BD4B9
wdt:P1433
wd:Q15724525
p:P433
wds:Q38508715-7BEBB541-1566-4D21-AAF8-8A1C7E2133AF
p:P478
wds:Q38508715-4BFD60BF-E703-4652-B619-A74ACE207AF3
wdt:P433
2
wdt:P478
64
p:P356
wds:Q38508715-D324BEFE-02F5-4A84-ABCF-9AEBAB2BE906
wdtn:P356
n11:S0015-0282(16)57729-2
wdt:P356
10.1016/S0015-0282(16)57729-2